{
    "2021-03-19": [
        [
            {
                "time": "",
                "original_text": "医联携手金域医学 打造慢病管理领域云检测整合服务方案",
                "features": {
                    "keywords": [
                        "医联",
                        "金域医学",
                        "慢病管理",
                        "云检测",
                        "整合服务"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "金域医学(603882.SH)：股东圣域钫质押375万股",
                "features": {
                    "keywords": [
                        "金域医学",
                        "股东",
                        "圣域钫",
                        "质押",
                        "375万股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：业绩弹性逐步释放 关注一季报高增长品种",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩弹性",
                        "一季报",
                        "高增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}